These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21536370)

  • 21. The IGF system in metabolism regulation.
    Binoux M
    Diabete Metab; 1995 Dec; 21(5):330-7. PubMed ID: 8586149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?
    Meinbach DS; Lokeshwar BL
    Urol Oncol; 2006; 24(4):294-306. PubMed ID: 16818181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in benign prostatic hyperplasia].
    Yu JP; Wu XM; Chen JG; Liu WM; Yang QX
    Zhonghua Nan Ke Xue; 2003 Aug; 9(5):341-3. PubMed ID: 14513639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels.
    Bonnet P; Reiter E; Bruyninx M; Sente B; Dombrowicz D; de Leval J; Closset J; Hennen G
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1203-8. PubMed ID: 7521342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign prostatic hyperplasia: does lifestyle play a role?
    Barnard RJ; Aronson WJ
    Phys Sportsmed; 2009 Dec; 37(4):141-6. PubMed ID: 20048551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokines and BPH/LUTS.
    Macoska JA
    Differentiation; 2011; 82(4-5):253-60. PubMed ID: 21600689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgens and estrogens in benign prostatic hyperplasia: past, present and future.
    Nicholson TM; Ricke WA
    Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The insulin-like growth factor system in the prostate.
    Peehl DM; Cohen P; Rosenfeld RG
    World J Urol; 1995; 13(5):306-11. PubMed ID: 8581002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-ARI induces autophagy of prostate epithelial cells through suppressing IGF-1 expression in prostate fibroblasts.
    Yang BY; Jiang CY; Dai CY; Zhao RZ; Wang XJ; Zhu YP; Qian YX; Yin FL; Fu XY; Jing YF; Han BM; Xia SJ; Ruan Y
    Cell Prolif; 2019 May; 52(3):e12590. PubMed ID: 30883989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literature.
    Breyer BN; Sarma AV
    Curr Urol Rep; 2014 Dec; 15(12):462. PubMed ID: 25287259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benign prostate hyperplasia and stem cells: a new therapeutic opportunity.
    Notara M; Ahmed A
    Cell Biol Toxicol; 2012 Dec; 28(6):435-42. PubMed ID: 23065175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D and benign prostatic hyperplasia -- a review.
    Espinosa G; Esposito R; Kazzazi A; Djavan B
    Can J Urol; 2013 Aug; 20(4):6820-5. PubMed ID: 23930605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin inhibits the proliferation of benign prostatic epithelial cells.
    Wang Z; Xiao X; Ge R; Li J; Johnson CW; Rassoulian C; Olumi AF
    PLoS One; 2017; 12(3):e0173335. PubMed ID: 28253329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue.
    Crescioli C; Villari D; Forti G; Ferruzzi P; Petrone L; Vannelli GB; Adorini L; Salerno R; Serio M; Maggi M
    Mol Cell Endocrinol; 2002 Dec; 198(1-2):69-75. PubMed ID: 12573816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrinology of the Aging Prostate: Current Concepts.
    Cannarella R; Condorelli RA; Barbagallo F; La Vignera S; Calogero AE
    Front Endocrinol (Lausanne); 2021; 12():554078. PubMed ID: 33692752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of metformin on prostatic tissue of rats with metabolic syndrome and benign prostatic hyperplasia.
    Xu C; Xu Y; Shen Z; Zhou H; Xiao J; Huang T
    Int Urol Nephrol; 2018 Apr; 50(4):611-617. PubMed ID: 29460133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of the IGF System with Diabetes and its Vascular Complications.
    Narayanan RP; Siddals KW; Heald AH; Gibson JM
    Exp Clin Endocrinol Diabetes; 2013 May; 121(5):255-61. PubMed ID: 23430576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine control of benign prostatic hyperplasia.
    La Vignera S; Condorelli RA; Russo GI; Morgia G; Calogero AE
    Andrology; 2016 May; 4(3):404-11. PubMed ID: 27089546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.